MOTS-C research: the mitochondrial exercise-mimetic peptide
MOTS-C research: how this mitochondrial-derived peptide is studied for AMPK activation, insulin sensitivity, metabolism and ageing, plus data limits. RUO.
Melanotan 2 research: melanocortin agonist and pigmentation
Melanotan 2 research: how this melanocortin agonist drives melanogenesis and pigmentation, plus the difference with melanotan 1. RUO, not approved.
GHK-Cu research: what science shows about the copper peptide
What does GHK-Cu research show? How the copper peptide is studied in laboratory studies for collagen, skin rejuvenation and wound healing. RUO.
CJC-1295 research: DAC vs no-DAC and the GH axis explained
CJC-1295 research: the GHRH mechanism, the difference between DAC and no-DAC, and the combination with ipamorelin. RUO.
Ipamorelin research: the selective GH secretagogue explained
Ipamorelin research: how this selective GH secretagogue and ghrelin receptor agonist stimulates GH release in preclinical studies. RUO.
Semaglutide research: from SUSTAIN and STEP to the SELECT study
Overview of semaglutide research: the GLP-1 mechanism and the studies SUSTAIN, STEP and SELECT. Solely for in-vitro laboratory research (RUO).
Tirzepatide research: the dual GIP/GLP-1 agonist explained
Tirzepatide research explained: how the dual GIP/GLP-1 agonist works and what the SURPASS and SURMOUNT studies reported. RUO — for laboratory research.
Retatrutide research: the triple agonist explained
Retatrutide (LY3437943) is a triple GLP-1/GIP/glucagon agonist. What research shows about fat loss and metabolism — RUO, HPLC-tested.
Knowledge base
Fat-loss peptides: the overview of metabolic research
Fat-loss peptides overview: HGH fragments, metabolic activators, lipotropic substances and GLP-1 in lipolysis and metabolism research. RUO.
Knowledge base
Cognitive peptides: the overview of neuro research
Cognitive peptides overview: Semax, Selank, Adamax, Pinealon, DSIP and orexin in neuro- and nootropic research, with links to each pillar. RUO.